Here is what the page “Nonprofit Revives Shelved Gene Therapy After Bloomsbury Genetic Therapies Shuts Down” contains. startup Bloomsbury Genetic Therapies shut down last year is getting a second chance. The company, which had dosed just one patient before ceasing operations, has handed its lead program to a nonprofit organization dedicated to advancing treatments that might o The company, which had dosed just one patient before ceasing operations, has handed its lead program to a nonprofit organization dedicated to advancing treatments that might otherwise be abandoned.
The nonprofit, whose name was not disclosed in the original report, will now take over development of the experimental therapy, aiming to push it toward clinical trials and, potentially, regulatory approval. This move highlights a growing trend in biotech: rescuing promising therapies that fall victim to financial or strategic setbacks, rather than letting them disappear. For the complete material, the listing points back to the source inside the network.